Applied Therapeutics Inc.
(APLT)
undefined
undefined%
At close: undefined
0.94
-0.18%
After-hours Jan 03, 2025, 05:49 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | 9.99M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 353.00K | 441.00K | 415.00K | 380.00K | 23.00K | n/a | n/a |
| Gross Profit | 9.64M | -441.00K | -415.00K | -380.00K | -23.00K | n/a | n/a |
| Operating Income | -64.53M | -82.95M | -105.62M | -94.47M | -45.58M | -13.52M | -4.29M |
| Interest Income | 1.37M | 685.00K | 555.00K | 559.00K | 93.00K | n/a | n/a |
| Pretax Income | -119.76M | -82.51M | -105.58M | -93.96M | -45.51M | -16.52M | -4.28M |
| Net Income | -119.76M | -81.69M | -104.61M | -93.02M | -45.40M | -16.52M | -4.28M |
| Selling & General & Admin | 20.62M | 27.32M | 43.05M | 32.68M | 13.23M | 2.05M | 582.00K |
| Research & Development | 53.91M | 55.63M | 62.57M | 61.79M | 32.35M | 11.47M | 3.70M |
| Other Expenses | n/a | -177.00K | -521.00K | -54.00K | -24.00K | -1.14M | n/a |
| Operating Expenses | 74.53M | 82.95M | 105.62M | 94.47M | 45.58M | 13.52M | 4.29M |
| Interest Expense | n/a | n/a | 555.00K | 559.00K | 93.00K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 74.53M | 82.95M | 105.62M | 94.47M | 45.58M | 13.52M | 4.29M |
| Income Tax | n/a | -819.00K | -970.00K | -939.00K | -116.00K | 4.87M | -4.29M |
| Shares Outstanding (Basic) | 84.24M | 37.83M | 25.60M | 21.97M | 12.83M | 9.16M | 9.16M |
| Shares Outstanding (Diluted) | 84.24M | 37.83M | 25.60M | 21.97M | 12.83M | 9.16M | 9.16M |
| EPS (Basic) | -1.42 | -2.16 | -4.09 | -4.23 | -3.54 | -1.8 | -0.47 |
| EPS (Diluted) | -1.42 | -2.16 | -4.09 | -4.23 | -3.54 | -1.8 | -0.47 |
| EBITDA | -64.53M | -82.07M | -105.17M | -94.47M | -45.58M | -3.00M | 3.00K |
| Depreciation & Amortization | 1K | 441.00K | 415.00K | 380.00K | 23.00K | 13.52M | 4.29M |